Inhibition of hypothalamic Foxo1 expression reduced food intake in diet-induced obesity rats

Inhibition of hypothalamic Foxo1 expression reduced food intake in diet-induced obesity rats

Author Ropelle, Eduardo R. Google Scholar
Pauli, Jose R. Autor UNIFESP Google Scholar
Prada, Patricia Google Scholar
Cintra, Dennys E. Google Scholar
Rocha, Guilherme Z. Google Scholar
Moraes, Juliana C. Google Scholar
Frederico, Marisa J. S. Google Scholar
Luz, Gabrielle da Google Scholar
Pinho, Ricardo A. Google Scholar
Carvalheira, Jose B. C. Google Scholar
Velloso, Licio A. Google Scholar
Saad, Mario A. Google Scholar
De Souza, Claudio T. Google Scholar
Institution Univ Extremo Catarinense
Universidade Estadual de Campinas (UNICAMP)
Universidade Federal de São Paulo (UNIFESP)
Abstract Insulin signalling in the hypothalamus plays a role in maintaining body weight. the forkhead transcription factor Foxo1 is an important mediator of insulin signalling in the hypothalamus. Foxo1 stimulates the transcription of the orexigenic neuropeptide Y and Agouti-related protein through the phosphatidylinositol-3-kinase/Akt signalling pathway, but the role of hypothalamic Foxo1 in insulin resistance and obesity remains unclear. Here, we identify that a high-fat diet impaired insulin-induced hypothalamic Foxo1 phosphorylation and degradation, increasing the nuclear Foxo1 activity and hyperphagic response in rats. Thus, we investigated the effects of the intracerebroventricular (i.c.v.) microinfusion of Foxo1-antisense oligonucleotide (Foxo1-ASO) and evaluated the food consumption and weight gain in normal and diet-induced obese (DIO) rats. Three days of Foxo1-ASO microinfusion reduced the hypothalamic Foxo1 expression by about 85%. i.c.v. infusion of Foxo1-ASO reduced the cumulative food intake (21%), body weight change (28%), epididymal fat pad weight (22%) and fasting serum insulin levels (19%) and increased the insulin sensitivity (34%) in DIO but not in control animals. Collectively, these data showed that the Foxo1-ASO treatment blocked the orexigenic effects of Foxo1 and prevented the hyperphagic response in obese rats. Thus, pharmacological manipulation of Foxo1 may be used to prevent or treat obesity.
Language English
Sponsor Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Date 2009-05-15
Published in Journal of Physiology-london. Malden: Wiley-Blackwell Publishing, Inc, v. 587, n. 10, p. 2341-2351, 2009.
ISSN 0022-3751 (Sherpa/Romeo, impact factor)
Publisher Wiley-Blackwell
Extent 2341-2351
Origin http://dx.doi.org/10.1113/jphysiol.2009.170050
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000266491300020
URI http://repositorio.unifesp.br/handle/11600/31520

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account